Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2i
Meeting report with video, highlights and slides of a PACE-CME symposium held during virtual ERA-EDTA 2020 on the evolving role of SGLT2i in cardiovascular and kidney protection
Episodes 1-3 of 3
- Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2iTargeting cardiovascular and kidney outcomes in CKD: Where do we stand today?
Prof. Christoph Wanner
- Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2iThe cardiorenal connection and diabetes: Exploring intervention by SGLT2i
Maria Rosa Costanzo, MD
- Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2iKidney protection and SGLT2i: What do we know?
Prof. Mark Cooper, MD
